The use of molecular diagnostics in bladder cancer

Research output: Contribution to journalReview articlepeer-review

28 Scopus citations


Bladder cancer is a common disease that causes significant morbidity and mortality in the United States. Early detection and routine surveillance are recommended in the management of this chronic and recurrent disease. Cystoscopic examination has been used for detection and follow-up; however, it is costly and is associated with patient discomfort. With advances in molecular biology and biochemistry, many diagnostic assays have been developed to supplement cystoscopy. The mechanisms and variable results of these assays are described. In addition, the economic and social implications of bladder cancer detection and surveillance are discussed. Copyright (C) 2000 Elsevier Science Inc.

Original languageEnglish (US)
Pages (from-to)87-92
Number of pages6
JournalUrologic Oncology
Issue number3
StatePublished - Apr 5 2000
Externally publishedYes


  • Bladder neoplasms
  • Transitional cell
  • Tumor markers

ASJC Scopus subject areas

  • Oncology
  • Urology


Dive into the research topics of 'The use of molecular diagnostics in bladder cancer'. Together they form a unique fingerprint.

Cite this